The influence of labor and placental separation on hemostasis in term pregnancy

Clinical and Applied Thrombosis/Hemostasis

Volumn 4, Issue 4, 1998, Pages 262-267

  Koh, Stephen C L ^a   Arulkumaran, Sabaratnam ^a   Biswas, Arijit ^a   Ratnam, S Shan ^a  

^a NATIONAL UNIVERSITY HOSPITAL   (Singapore)

Author keywords

Hemostatic factors during labor and delivery

Indexed keywords

ANTITHROMBIN III; BLOOD CLOTTING FACTOR 7; D DIMER; FIBRINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLASMINOGEN ACTIVATOR INHIBITOR 2; PROTEIN C; PROTEIN S; THROMBIN; THROMBIN ANTITHROMBIN COMPLEX;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; FIBRINOLYSIS; HEMOSTASIS; HUMAN; HYPERCOAGULABILITY; LABOR; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; PLACENTA; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; THROMBOELASTOGRAPHY;

EID: 0031664382     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/107602969800400409     Document Type: Article

References (33)

1. Stirling Y, Woolf L, North WRS, et al. Haemostasis in normal pregnancy. Thromb Haemost 1984;52:176.
2. Weiner CP, Kwaan H, Hauck W, et al. Fibrin generation in normal pregnancy. Obstet Gynecol 1984;64:46.
3. De Boer K, ten Cate JW, Sturk A, et al. Enhanced thrombin generation in normal and hypertensive pregnancy. Am J Obstet Gynecol 1989;160:95.
4. Koh CLS, Ratnam SS. Haemostatic trends in normal pregnancy in Chinese women. J Obstet Gynaecol 1989;9:271.
5. Koh CLS, Viegas OAC, Yuen R, et al. Plasminogen activators and inhibitors in normal late pregnancy, postpartum and in the postnatal period. Int J Gynaecol Obstet 1992;38:9.
6. Bonnar J, McNicol GP, Douglas AS. Fibrinolytic enzyme system and pregnancy. Br Med J 1969;3:387.
7. Howie PW. Blood clotting and fibrinolysis in inpregnancy. Post-grad Med J 1979;55:362.
8. Mackinnon S, Walker ID, Davidson JF, Walker JJ. Plasma fibrinolysis during and after childbirth. Br J Haematol 1987;65:339.
9. Shimada H, Takashima E, Soma M, et al. Source of increased plasminogen activators during pregnancy and puerperium. Thromb Res 1989;54:91.
10. Yoshimura T, Ito M, Nakamura T, Okamura H. The influence of labour on thrombin and fibrinolytic systems. Eur J Obstet Gynecol Reprod Biol 1992;44:195.
11. Andersson T, Lorentzen B, Hogdahl H, et al. Thrombin-inhibitor complexes in the blood during and after delivery. Thromb Res 1996;82:109.
12. Gerbasi FR, Borttoms S, Farag A, Mammen EF. Changes in hemostasis activity during delivery and the immediate postpartum period. Am J Obstet Gynecol 1990;162:1158.
13. Kruithof EKO, Chien T-T, Gudineher A, et al. Fibrinolysis in pregnancy: a study of plasminogen activator inhibitors. Blood 1987;69:460.
14. Ballegeer VC, Spitz B, DeBaene Luc A, et al. Platelet activation in vascular damage in gestational hypertension. Am J Obstet Gynecol 1992;166:629.
15. Wallenburg HCF, Sharp S, Symonds EH. Changes in the coagulation system and platelets in pregnancy induced hypertension and pre-eclampsia. Hypertension in pregnancy. Ithaca, New York: Perinatology Press, 1986:227.
16. Haznedaroglu S, Ozcan T, Malkoc S, et al. Molecular markers of hemostatic activation in pre-eclampsia. Clin Appl Thromb Hemost 1997;3:294.
17. Koh SCL, Anandakumar C, Montan S, Ratnam SS. Plasminogen activation, plasminogen activator inhibitors and markers of intra-vascular coagulation in pre-eclampsia. Gynecol Obstet Invest 1993;35:214.
18. Freinkel N. Banting Lecture 1980. Of pregnancy and progeny. Diabetes 1980;29:1023.
19. Pettitt J, Bennett PH, Knowler WC, et al. Gestational diabetes mellitus and impaired glucose tolerance during pregnancy. Diabetes 1985;34 (suppl 2): 119.
20. Koh SCL, Cheong YS, Arulkumaran S, Ratnam SS. Coagulation activation, fibrinolysis and inhibitors in neonates. Ann Acad Med Singapore 1997;26:767.
21. Koh SCL, Chew C, Viegas OAC, et al. Thrombelastography in normal subjects and in various clinical states. J Med Lab Scs 1993; 7:29.
22. Koh SCL, Yuen R, Viegas OAC, et al. A plasmin generation method for the determination of t-PA in blood. Immunol Cell Biol 1989;67:197.
23. Koh SCL, Yuen R, Viegas OAC, Ratnam SS. Plasma urokinase activity and antigen levels in normal males, females and in late pregnancy. Med Sci Res 1992;20:601.
24. Koh SCL, Yuen R, Viegas OAC, et al. Plasma tissue plasminogen activator inhibitor (t-PAI) activity in normal subjects. Med Sci Res 1989;17:135.
25. Kruithof EKO, Gudinchet A, Bachmann F. Plasminogen activator inhibitor 1 and plasminogen activator inhibitor 2 in various disease states. Thromb Haemost 1988;59:7.
26. De Boer K, Lecander I, ten Cate JW, et al. Placental-type plasminogen activation pre-eclampsia. Am J Obstet Gynecol 1988;158: 518.
27. Astedt B, Lecander I, Brodin T, et al. Purification of a specific placental plasminogen activator inhibitor by monoclonal antibody and its complex formation with plasminogen activator. Thromb Haemost 1985;53:122.
28. Lecander I, Astedt B. Specific plasminogen activator of placental type, PAI-2 occurring in amniotic fluid and cord blood. J Lab Clin Med 1987;110:602.
29. Salch AA, Gerbasi FR, Mammen EF, Farag A. Increased platelet activation in preterm labour. Thromb Res 1992;65:475.
30. Gilabert J, Estelles A, Espana F. Fibrinolytic activity and protein C in pre-eclampsia. Thromb Haemost 1986;55:314.
31. Hopmeier P, Halbmayer M, Schwarz HP, et al. Protein C and protein S in mild and moderate preeclampsia. Thromb Haemost 1987;58:794.
32. Comp PC, Thurnau GR, Weksh J, Esmon Ch T. Functional and immunologic protein S levels are decreased during pregnancy. Blood 1981;68:881.
33. Weiner CP, Brandt J. Plasma antithrombin III activity in normal pregnancy. Obstet Gynecol 1980;56:601.